Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.

Jiang SW, Chen H, Dowdy S, Fu A, Attewell J, Kalogera E, Drapkin R, Podratz K, Broaddus R, Li J.

Int J Mol Sci. 2013 Nov 18;14(11):22655-77. doi: 10.3390/ijms141122655.

PMID:
24252907
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.

Bignotti E, Ragnoli M, Zanotti L, Calza S, Falchetti M, Lonardi S, Bergamelli S, Bandiera E, Tassi RA, Romani C, Todeschini P, Odicino FE, Facchetti F, Pecorelli S, Ravaggi A.

Br J Cancer. 2011 Apr 26;104(9):1418-25. doi: 10.1038/bjc.2011.109. Epub 2011 Apr 5.

PMID:
21468050
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].

Zhang G, Li XP, Wang JL, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):839-45. Chinese.

PMID:
23302125
[PubMed - indexed for MEDLINE]
4.

Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.

Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Mar;96(3):601-9.

PMID:
15721400
[PubMed - indexed for MEDLINE]
5.

Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.

Tokuishi K, Yamashita S, Ohbo K, Kawahara K.

Tumour Biol. 2012 Feb;33(1):103-9. doi: 10.1007/s13277-011-0252-8. Epub 2011 Oct 21.

PMID:
22015929
[PubMed - indexed for MEDLINE]
6.

Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.

Witek A, Paul-Samojedny M, Stojko R, Seifert B, Mazurek U.

Gynecol Oncol. 2007 Aug;106(2):407-12. Epub 2007 Jun 11.

PMID:
17561234
[PubMed - indexed for MEDLINE]
7.

Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.

Giannice R, Erreni M, Allavena P, Buscaglia M, Tozzi R.

Cytokine. 2013 Nov;64(2):509-15. doi: 10.1016/j.cyto.2013.07.024. Epub 2013 Aug 25.

PMID:
23985752
[PubMed - indexed for MEDLINE]
8.

High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.

Bellone S, Watts K, Cane' S, Palmieri M, Cannon MJ, Burnett A, Roman JJ, Pecorelli S, Santin AD.

Gynecol Oncol. 2005 Jul;98(1):92-8.

PMID:
15904949
[PubMed - indexed for MEDLINE]
9.

Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.

Zhang B, zur Hausen A, Orlowska-Volk M, J├Ąger M, Bettendorf H, Stamm S, Hirschfeld M, Yiqin O, Tong X, Gitsch G, Stickeler E.

Int J Gynecol Cancer. 2010 May;20(4):492-9. doi: 10.1111/IGC.0b013e3181d66ffe.

PMID:
20686370
[PubMed - indexed for MEDLINE]
10.

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, Jiang SW, Podratz K, Urban N, Dowdy SC.

Gynecol Oncol. 2012 Feb;124(2):270-5. doi: 10.1016/j.ygyno.2011.10.025. Epub 2011 Oct 28.

PMID:
22037318
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Hypomethylation-induced expression of S100A4 in endometrial carcinoma.

Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr, Broaddus RR.

Mod Pathol. 2007 Oct;20(10):1045-54. Epub 2007 Aug 3.

PMID:
17673926
[PubMed - indexed for MEDLINE]
Free Article
12.

Serum HE4 as a prognostic marker in endometrial cancer--a population based study.

Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A.

Gynecol Oncol. 2014 Jan;132(1):159-65. doi: 10.1016/j.ygyno.2013.10.036. Epub 2013 Nov 6.

PMID:
24211402
[PubMed - indexed for MEDLINE]
13.

FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.

Soufla G, Sifakis S, Spandidos DA.

Cancer Lett. 2008 Feb 8;259(2):146-55. Epub 2007 Nov 19.

PMID:
18006148
[PubMed - indexed for MEDLINE]
14.

Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.

Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M.

Int J Cancer. 1999 Jan 5;80(1):60-3.

PMID:
9935231
[PubMed - indexed for MEDLINE]
15.

Presence of alternatively spliced-estrogen receptor mRNA variants in normal human uterine endometrium and endometrial cancer.

Hirata S, Yamada-Mouri N, Nara M, Takizawa M, Ito H, Kato J.

Endocr J. 1995 Apr;42(2):289-93.

PMID:
7542977
[PubMed - indexed for MEDLINE]
Free Article
16.

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S.

Clin Cancer Res. 2005 May 1;11(9):3320-5.

PMID:
15867230
[PubMed - indexed for MEDLINE]
Free Article
17.

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Galgano MT, Hampton GM, Frierson HF Jr.

Mod Pathol. 2006 Jun;19(6):847-53.

PMID:
16607372
[PubMed - indexed for MEDLINE]
Free Article
18.

Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.

Deng L, Broaddus RR, McCampbell A, Shipley GL, Loose DS, Stancel GM, Pickar JH, Davies PJ.

Clin Cancer Res. 2005 Dec 1;11(23):8258-64.

PMID:
16322283
[PubMed - indexed for MEDLINE]
Free Article
19.

Pattern of tissue expression of CA-125 and HE4 in primary epithelial ovarian tumours and correlation with serum CA-125 levels.

Devan SM, Pailoor J, Sthaneshwar P, Narayanan V.

Asian Pac J Cancer Prev. 2013;14(8):4545-8.

PMID:
24083699
[PubMed - indexed for MEDLINE]
Free Article
20.

Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.

Watari H, Xiong Y, Hassan MK, Sakuragi N.

Gynecol Oncol. 2009 Jan;112(1):229-34. doi: 10.1016/j.ygyno.2008.09.039. Epub 2008 Nov 12.

PMID:
19007976
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk